Adrenaline of epinephrine can be seen in autonomic neuropathy or following adrenalectomy. Failure of the adrenal cortex, as with Addisons disease, can suppress epinephrine secretion as the activity of the synthesing enzyme, phenylethanolamine-"N"-methyltransferase, depends on the high concentration of cortisol that drains from the cortex to the medulla. In 1901, Jokichi Takamine patented a purified extract from the adrenal glands, and called it "adrenalin" (from the Latin for "on top of the kidneys" ("ad" and "renal"), which was trademarked by Parke, Davis & Co in the US. The British Approved Name and European Pharmacopoeia term for this drug is hence "adrenaline".
European Federation of Autonomic Societies European Federation of Autonomic Societies The European Federation of Autonomic Societies (EFAS) is a scientific society which aims of coordinate the activity of national autonomic societies within Europe. The focus of these societies is the study of the Autonomic nervous system, particularly clinical aspects of this field. The society was founded in October 1998. EFAS holds an annual congress, organized each year by another national autonomic society. Since the autonomic field in fact overlaps with a number of disciplines, several were held as joint meetings with partnering international societies. Partnering organizations for meetings had been the International Society for Autonomic